Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Signed informed consent form.
Healthy participants, determined by medical history, physical examination, electrocardiograms (ECGs) and clinical laboratory tests.
Weight between 60.0 to 100.0 kg, inclusive.
Body Mass Index (BMI) of 18.0 to 30.0 kg/m2, inclusive.
Women of childbearing potential (WOCBP) must have a negative pregnancy test within 24 hours prior to the start of study treatment.
WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment and for a total of 80 days after treatment ends.
Women must not be breastfeeding.
Males who are sexually active with WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment and for a total of 140 days after treatment ends. In addition, male participants must not donate sperm during this time.
You may not be if
Participants with active tuberculosis (TB) requiring treatment; a history of active or latent TB without documented adequate therapy; or with current clinical, radiographic or laboratory evidence fo active or latent TB.
History of shingles (herpes zoster).
Personal or strong family history of cancer.
Use of tobacco- or nicotine-containing products (including, but not limited to, cigarettes, pipes, cigars, e-cigarettes, chewing tobacco, nicotine patches, nicotine lozenges, or nicotine gum) within 6 months prior to study treatment administration.
Any known or suspected autoimmune disorder.
Clareo Health | A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes
